Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON

 (JNJ)

89
Real-time Quote. Real-time BATS US - 05/24 04:59:59 pm
88.95 USD   +2.00%
2d agoDJBausch & Lomb Nears $9 Billion Sale to Valeant
3d agoDJ4TH UPDATE: J&J to Submit More Than 10 New Drug Applications by 2017
3d agoDJJ&J to Submit More Than 10 New Drug Applications by 2017
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/20/2013 05/21/2013 05/22/2013 05/23/2013 05/24/2013 Date
88.01(c) 88.59(c) 88.46(c) 87.21(c) 86.82(c) Last
7 235 972 10 099 587 13 827 735 14 446 889 10 291 171 Volume
-0.09% +0.66% -0.15% -1.41% -0.45% Change
More quotes
Company
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - medical products and equipment (40.8%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare... 
Surperformance© rating of Johnson & Johnson
Trading Rating : Investor Rating :
More about the company
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 70 882 M
EBIT 2013 18 932 M
Net income 2013 14 562 M
Finance 2013 13 389 M
Yield 2013 2,85%
Sales 2014 73 809 M
EBIT 2014 20 336 M
Net income 2014 15 969 M
Finance 2014 22 283 M
Yield 2014 3,03%
PER 2013 16,80
PER 2014 15,30
EV / Sales 2013 3,25x
EV / Sales 2014 3,00x
Capitalization 243 868 M
More Financials
Latest news on JOHNSON & JOHNSON
2d agoDJBausch & Lomb Nears $9 Billion Sale to Valeant
3d agoDJ4TH UPDATE: J&J to Submit More Than 10 New Drug Applications by 2017
3d agoDJJ&J to Submit More Than 10 New Drug Applications by 2017
3d agoDJJ&J to Submit Over 10 New Drug Applications by 2017
3d agoDJJ&J To Submit Over 10 New Drug Applications By 2017
3d agoDJJOHNSON & JOHNSON: to Submit 10 New Product Filings by 2017
3d ago JOHNSON & JOHNSON: Pharmaceuticals Segment Poised to Continue Driving Growth wi..
3d ago JOHNSON & JOHNSON: ex-dividend day
4d ago JOHNSON & JOHNSON: Pharmaceuticals Business Review
5d ago JOHNSON & JOHNSON: Cordis Showcases Cardiovascular Innovations at EuroPCR 2013
6d agoDJElan Sets Out Deal Plans
05/17DJJOHNSON & JOHNSON: Correction to Thursday's Johnson & Johnson-Metal-on-Metal Hi..
More news
4-Traders Strategies on JOHNSON & JOHNSON 
2012Towards historic highs
2012Beginning of a bearish movement
More Strategies
Forum JOHNSON & JOHNSON
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Johnson _ Johnson : Income Statement Evolution
More Financials
EPS Revisions
Johnson _ Johnson : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.